Tumor location and patient age predict biological signatures of high-grade gliomas

Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma

(2017) Egesta Lopci et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Reliability of noncontrast-enhancing tumor as a biomarker of IDH1 mutation status in glioblastoma

(2017) Arian Lasocki et al.   JOURNAL OF CLINICAL NEUROSCIENCE

IDH mutation and 1p19q codeletion distinguish two radiological patterns of diffuse low-grade gliomas

(2017) Amélie Darlix et al.   JOURNAL OF NEURO-ONCOLOGY

Diagnostic and Therapeutic Biomarkers in Glioblastoma: Current Status and Future Perspectives

(2017) Wojciech Szopa et al.   Biomed Research International

The impact of MGMT methylation and IDH-1 mutation on long-term outcome for glioblastoma treated with chemoradiotherapy

(2016) Christopher P. Millward et al.   ACTA NEUROCHIRURGICA

Spatial transcriptome analysis reveals Notch pathway-associated prognostic markers in IDH1 wild-type glioblastoma involving the subventricular zone

(2016) Christine Jungk et al.   BMC Medicine

Defining the cutoff value of MGMT gene promoter methylation and its predictive capacity in glioblastoma

(2016) Giovanni Brigliadori et al.   JOURNAL OF NEURO-ONCOLOGY

Outcome in unresectable glioblastoma: MGMT promoter methylation makes the difference

(2016) Niklas Thon et al.   JOURNAL OF NEUROLOGY

Radiogenomics of Glioblastoma: Machine Learning–based Classification of Molecular Characteristics by Using Multiparametric and Multiregional MR Imaging Features

(2016) Philipp Kickingereder et al.   RADIOLOGY

Predictors of survival and effect of short (40 Gy) or standard-course (60 Gy) irradiation plus concomitant temozolomide in elderly patients with glioblastoma: a multicenter retrospective study of AINO (Italian Association of Neuro-Oncology)

(2015) Giuseppe Lombardi et al.   JOURNAL OF NEURO-ONCOLOGY

Radiological and Pathological Features Associated with IDH1-R132H Mutation Status and Early Mortality in Newly Diagnosed Anaplastic Astrocytic Tumours

(2015) Jason K. Wasserman et al.   PLoS One

MGMT promoter methylation in plasma of glioma patients receiving temozolomide

(2014) Valentina Fiano et al.   JOURNAL OF NEURO-ONCOLOGY

Probabilistic Radiographic Atlas of Glioblastoma Phenotypes

(2012) B.M. Ellingson et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Relationship of glioblastoma multiforme to the subventricular zone is associated with survival

(2012) Nazia F. Jafri et al.   NEURO-ONCOLOGY

Correlation of IDH1 Mutation with Clinicopathologic Factors and Prognosis in Primary Glioblastoma: A Report of 118 Patients from China

(2012) Wei Yan et al.   PLoS One

Evidence for Sequenced Molecular Evolution of IDH1 Mutant Glioblastoma From a Distinct Cell of Origin

(2011) Albert Lai et al.   JOURNAL OF CLINICAL ONCOLOGY

Corridors of migrating neurons in the human brain and their decline during infancy

(2011) Nader Sanai et al.   NATURE

Anatomic localization of O6-methylguanine DNA methyltransferase (MGMT) promoter methylated and unmethylated tumors: A radiographic study in 358 de novo human glioblastomas

(2011) Benjamin M. Ellingson et al.   NEUROIMAGE

Extent of resection influences outcomes for patients with gliomas

(2011) N. Sanai et al.   REVUE NEUROLOGIQUE